Sarah Scagliarini/X
May 18, 2025, 13:31
Sarah Scagliarini: Working Together to Improve PROs in Cancer Trials and RWE
Sarah Scagliarini, Medical Oncologist at AORN Cardarelli in Naples, shared a post on X by ESMO, adding:
“Very interesting! In adj more than m cancer! But without data it will seem just a suggestion… so let’s all work together to improve PROs (different for each tumor/therapy as Cristiane Bergerot’s work) in all RCTs and investigate in RWE the differences with CROs!”
Quoting European Society for Medical Oncology (ESMO)’s post:
“Do clinicians and patients see the same picture? In adjuvant BC therapy trials, agreement on side effects is weak. Patient-reported outcomes (PROs) show symptoms that doctors often don’t see. Both views are vital for patient-centred care.”
Sarah Scagliarini responded to an ESMO post highlighting discrepancies between clinician and patient perspectives on side effects in adjuvant breast cancer therapy. She underscored the need for better integration of patient-reported outcomes (PROs) in randomized clinical trials and real-world evidence, referencing the work of Cristiane Bergerot as a model for tumor- and therapy-specific approaches.
More posts featuring ESMO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 18, 2025, 13:31
May 18, 2025, 12:54
May 18, 2025, 12:38
May 18, 2025, 11:49
May 18, 2025, 11:43